DMTRF.US 3-D Matrix Ltd

Healthcare Health Care Equipment & Supplies USA Stocks
2.43 USD
Close of Nov 14, 2026
1.50 3.96
Market cap
USD 310M
P/E
14.3x
P/B
6.83x
ROE
17.3%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jul 2026.

Is DMTRF.US undervalued?

Graham number
Price2.43
Graham value1.17
Premium108.0%

DMTRF.US trades 108.0% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

3-D Matrix Ltd fundamental analysis

No fundamental analysis for 3-D Matrix Ltd yet.

3-D Matrix Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About 3-D Matrix Ltd

3-D Matrix, Ltd. developing, manufacturing, and selling self-assembling peptide technology in Japan and internationally. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the regenerative medicine, cell therapy, drug delivery systems, and other uses in various fields; and surfactant-like peptide, as well as High Concentration PuraMatrix, a high concentration hydrogel; and GMP Grade PuraMatrix. The company was incorporated in 2004 and is based in Tokyo, Japa…

Full company profile